Compare MBAI & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBAI | SINT |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | Israel | United States |
| Employees | 85 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 11.1M |
| IPO Year | N/A | 2007 |
| Metric | MBAI | SINT |
|---|---|---|
| Price | $1.76 | $2.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | ★ 72.9K | 24.8K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,018,000.00 |
| Revenue This Year | N/A | $80.35 |
| Revenue Next Year | N/A | $270.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.31 | $1.72 |
| 52 Week High | $3.92 | $6.78 |
| Indicator | MBAI | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 57.87 |
| Support Level | $1.38 | $2.60 |
| Resistance Level | $1.89 | $2.96 |
| Average True Range (ATR) | 0.19 | 0.19 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 40.85 | 78.22 |
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.